Enrollment in New Jersey’s insurance exchange during open enrollment this year trails last year’s sign-ups by 14%. That’s despite state efforts to enact an individual mandate, implement a reinsurance program and prohibit short-term insurance plans.
Four premature babies in the neonatal ICU have contracted the Acinetobacter baumannii bacteria since September, three of whom died, according to public health officials.
Generic-drug maker Sandoz will start selling an alternative to the EpiPen in the U.S. early next year. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.
Five metro Detroit doctors and one from the Grand Rapids area have been indicted for allegedly running a $464 million healthcare fraud scheme that involved millions of opioid drugs and unnecessary medical procedures in Southeastern Michigan.
Tariff battles, whether in 1992 or 2018, will not solve what remains one of U.S. businesses’ main international competitiveness problems: the higher prices they pay for healthcare and the tab’s uneven distribution.
The rate of U.S. healthcare spending growth slowed from 2016 to 2017, driven by reduced use and intensity of hospital care, physician services and prescription drugs, according to CMS’ Office of the Actuary.